Clues at the Scene of the Crime: Sudden Death in Dialysis Patients

USRDS. Table H.29. Mortality rates by primary cause of mortality, unadjusted. In: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the U.S. Bethesda, MD: National Institutes of Health: National Institute of Diabetes Digestive and Kidney Diseases; 2007: H.29.

Solomon S.D. , Zelenkofske S. , McMurray J.J. , Finn P.V. , Velazquez E. , Ertl G. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581–8.

Muller J.E. , Kaufmann P.G. , Luepker R.V. , Weisfeldt M.L. , Deedwania P.C. , Willerson J.T. Mechanisms precipitating acute cardiac arrest: review and recommendations of an NHLBI workshop. Circulation 1997; 96: 3233–9.

Siscovick D.S. , Raghunathan T.E. , Psaty B.M. , Koepsell T.D. , Wicklund K.G. , Lin X. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852.

Bleyer A.J. , Hartman J. , Brannon P.C. , Reeves-Daniel A. , Satko S.G. , Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268–73.

Raizada V. , Skipper B. , Luo W. , Garza L. , Hines C.W. , Harford A.A. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Kidney Int 2005; 68: 1186–9.

Cupisti A. , Galetta F. , Caprioli R. , Morelli E. , Tintori G.C. , Franzoni F. Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron 1999; 82: 122–6.

Foley R. , Parfrey P. , Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(5 Suppl 3): S112–19.

Karnik J.A. , Young B.S. , Lew N.L. , Herget M. , Dubinsky C. , Lazarus J.M. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350–7.

Bleyer A.J. , Russell G.B. , Satko S.G. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553–9.

Morrison G. , Michelson E.L. , Brown S. , Morganroth J. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 1980; 17: 811–19.

Lorincz I. , Matyus J. , Zilahi Z. , Kun C. , Karany Z. , Kakuk G. QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol 1999; 10: 1297–302.

Yildiz A. , Akkaya V. , Sahin S. , Tukek T. , Besler M. , Bozfakioglu S. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int 2001; 21: 186–92.

Chow K.M. , Szeto C.C. , Kwan B.C. , Chung K.Y. , Leung C.B. , Li P.K.T. Factors associated with sudden death in peritoneal dialysis patients. Perit Dial Int 2009; 29: 58–63.

Cice G. , Ferrara L. , Di Benedetto A. , Russo P.E. , Marinelli G. , Pavese F. Dilated cardiomyopathy in dialysis patients—beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol 2001; 37: 407–11.

Berger A.K. , Duval S. , Krumholz H.M. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42: 201–8.

Chamis A.L. , Peterson G.E. , Cabell C.H. , Corey G.R. , Sorrentino R.A. , Greenfield R.A. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104: 1029–33.

Herzog C.A. , Li S. , Weinhandl E.D. , Strief J.W. , Collins A.J. , Gilbertson D.T. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818–25.

Hreybe H. , Razak E. , Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007; 30: 1091–5.